SAN DIEGO, Aug. 16, 2016 /PRNewswire/ -- Forge Therapeutics, Inc. announced today Dr. Seth Cohen, Ph.D., co-founder of Forge Therapeutics and Professor in the Department of Chemistry and Biochemistry at the University of California, San Diego will be receiving the Arthur C. Cope Mid Career Scholar Award at the upcoming 252nd American Chemical Society National Meeting & Exposition being held in Philadelphia from August 21-25, 2016.
Dr. Cohen is being honored for advancements in metal-organic chemistry and insights into the identification of innovative pharmacophores for the development of metalloprotein inhibitors. These pharmacophores form the basis of the diverse library Forge has built up to provide starting points to develop inhibitors of a broad class of metalloenzymes.
"The Forge Therapeutics platform is truly transformational providing novel chemistry solutions to high value targets that have lacked suitable approaches until now," said Zachary A. Zimmerman, Ph.D., CEO of Forge Therapeutics. "This prestigious national chemistry award and our recent Federal funding provides further validation of our innovative approach for first-in-class and best-in-class medicines."
To learn more about 2016 National Award recipients please visit: https://www.acs.org/content/acs/en/funding-and-awards/awards/national/recipients/2016-national-award-recipients.html
About Forge Therapeutics, Inc.
Forge Therapeutics, Inc. ("Forge") is a biotechnology start-up that leverages its novel chemistry platform to develop small molecule inhibitors to target metalloproteins. Metalloproteins are proteins that require metal ions for their biological function and make up over 1/3 of the proteins in the human body. Forge uses a proprietary approach comprised of molecular modeling for rational drug design along with fundamental knowledge and expertise in bioinorganic chemistry to target metalloproteins. The name Forge Therapeutics comes from two definitions for forge: to manipulate (inhibit) a metal object (metalloprotein) and to move forward steadily with a purpose (the Forge team). Forge Therapeutics, Inc., maintains its headquarters in San Diego, California. To learn more please visit www.ForgeTherapeutics.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/forge-therapeutics-scientific-co-founder-awarded-national-chemistry-honor-300313694.html
SOURCE Forge Therapeutics, Inc.